Devices and methods for therapeutic heat treatment
An example implantable microparticle for delivering therapeutic heat treatment comprises a generally spherical body. The body may be formed from a first material comprising a biodegradable material and a second material comprising a Curie temperature material. The biodegradable material may be a non-Curie temperature material or have a Curie temperature lower than a Curie temperature of the Curie temperature material. The first material and the second material are mixed to form a composite having a Curie temperature in the range of 35° C. and 100° C.
1. An implantable microparticle comprising:
a generally spherical body comprising:
a first material comprising a biodegradable magnesium based compound or a biodegradable magnesium based alloy; and
a second material, different than the first material, comprising one or more of gallium arsenide, dysprosium, lanthanum iron oxide, lanthanide particles, LaFe—Si—H particles, cobalt, and neodymium, wherein the second material is distributed throughout the first material to avoid hot spots within the microparticle;
wherein the first material is a non-Curie temperature material or has a Curie temperature lower than a Curie temperature of the second material; and
wherein the first material and the second material form a composite having a Curie temperature in a range of 35° C. and 100° C.
2. The implantable microparticle of claim 1 , wherein a ratio of the first material to the second material is greater than 1:1.
3. The implantable microparticle of claim 1 , wherein the first material comprising the biodegradable magnesium based compound or the biodegradable magnesium based alloy is configured to degrade via oxidative corrosion.
4. The implantable microparticle of claim 1 , wherein the first material further comprises a biocompatible polymer.
5. The implantable microparticle of claim 1 , wherein the second material comprises a plurality of nanoparticles.
6. The implantable microparticle of claim 5 , wherein the plurality of nanoparticles each have a particle size in the range of 0.1 to 2.5 nanometers.
7. The implantable microparticle of claim 1 , further comprising a therapeutic agent.
8. The implantable microparticle of claim 7 , wherein the therapeutic agent is disposed on an outer surface of the spherical body.
9. The implantable microparticle of claim 7 , wherein the therapeutic agent is intermixed with the first material and the second material.
10. The implantable microparticle of claim 1 , wherein the microparticle is configured to degrade over a period of time in the range of 3 to 6 months.
11. The implantable microparticle of claim 1 , wherein the microparticle has a diameter in the range of 1-3000 microns.
12. The implantable microparticle of claim 1 , the generally spherical body further comprising a third Curie temperature material.
13. An implantable microparticle comprising:
a first material comprising a biodegradable magnesium based compound or a biodegradable magnesium based alloy; and
a second material, different than the first material, comprising an iron oxide, wherein the second material is distributed throughout the first material to avoid hot spots within the microparticle;
wherein the first material and the second material form a composite having a ratio of greater than 1:1 and a Curie temperature in the range of 35° C. and 100° C.
14. The implantable microparticle of claim 13 , wherein the iron oxide comprises at least one of iron (III) oxide (Fe 2 O 3 ), iron (II, III) oxide (FeO.Fe 2 O 3 ), or magnesium oxide iron (III) oxide (MgO.Fe 2 O 3 ).
15. A method of delivering therapeutic heat to a location within a body, the method comprising:
implanting at least one microparticle into the body adjacent to a desired treatment region, the microparticle comprising:
a generally spherical body having a diameter in the range of 1-3000 microns comprising:
a first material comprising a biodegradable magnesium based compound or a biodegradable magnesium based alloy; and
a second material, different than the first material, the second material comprising a plurality of iron oxide nanoparticles, wherein the second material is distributed throughout the first material to avoid hot spots within the microparticle;
wherein the first material is a non-Curie temperature material or has a Curie temperature lower than a Curie temperature of the second material; and
wherein the first material and the second material form a composite having a Curie temperature in the range of 35° C. and 100° C.;
generating a magnetic field at a location adjacent to the microparticle for a period of time to heat the microparticle to its Curie temperature; and
maintaining the microparticle at its Curie temperature for a period of time to achieve the desired therapeutic effect.
16. The method of claim 15 , wherein the steps of generating a magnetic field and maintaining the microparticle at its Curie temperature are repeated in discrete sessions separated by a length of time.
17. The method of claim 16 , wherein the steps of generating a magnetic field and maintaining the microparticle at its Curie temperature are repeated without implanting any additional microparticles.
18. The method of claim 15 , wherein the microparticle further comprise a therapeutic agent.